The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
In part 4 of our 2023 drug trends series, we’re evaluating workers’ comp high impact drug class patterns and strategies to address the challenges these cost drivers are creating.
In part 3 of our 2023 drug trends series, we’re evaluating workers’ comp opioid patterns and the strategies being used to continue their decline in use and manage their risks.
In part two of our 2023 drug trends series, we’re evaluating in-network and out-of-network prescription for a total view of prescription activity.
Events of 2013 point the way forward next year. Buzz words: cyber, health care and property.